Atrial fibrillation

Atrial fibrillation is the most common arrhythmia affecting patients today. Disease prevalence is increasing at an alarming rate worldwide, and is associated with often catastrophic and costly consequences, including heart failure, syncope, dementia, and stroke. Therapies including anticoagulants, anti-arrhythmic medications, devices, and non-pharmacologic procedures in the last 30 years have improved patients' functionality with the disease. Nonetheless, it remains imperative that further research into AF epidemiology, genetics, detection, and treatments continues to push forward rapidly as the worldwide population ages dramatically over the next 20 years.

[1]  David D. McManus,et al.  Atrial Fibrillation Atrial Fibrillation Current Knowledge and Future Directions in Epidemiology and Genomics , 2011 .

[2]  M. Allessie,et al.  Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. , 2000, Cardiovascular research.

[3]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[4]  B. Gersh,et al.  The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[5]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[6]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[7]  A. Gillis.  Angiotensin-receptor blockers for prevention of atrial fibrillation--a matter of timing or target? , 2009, The New England journal of medicine.

[8]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[9]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[10]  Rita A. Longaker,et al.  Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. , 1995, American heart journal.

[11]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[12]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[13]  Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery A Meta-Analysis , 2002 .

[14]  S Nattel,et al.  Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. , 2000, The New England journal of medicine.

[15]  A. Kadish,et al.  Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy. , 1989, Circulation.

[16]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[17]  Wen-tong Fang,et al.  The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. , 2012, British journal of clinical pharmacology.

[18]  S. Laffite,et al.  Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. , 2007, Journal of the American College of Cardiology.

[19]  S. Nattel,et al.  Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias , 2006, Circulation.

[20]  W. Manning,et al.  Exclusion of Atrial Thrombus by Transesophageal Echocardiography Does Not Preclude Embolism after Cardioversion of Atrial Fibrillation , 1994 .

[21]  R. Schoefl,et al.  Identification of a high-risk population for esophageal injury during radiofrequency catheter ablation of atrial fibrillation: procedural and anatomical considerations. , 2010, Heart rhythm.

[22]  A. Raviele,et al.  Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials. , 2008, Journal of atrial fibrillation.

[23]  R. Damiano,et al.  The surgical treatment of atrial fibrillation. , 2009, Heart rhythm.

[24]  S. Lévy,et al.  Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators. , 2000, Journal of the American College of Cardiology.

[25]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. , 2005, American heart journal.

[26]  W. Nelson,et al.  Prevalence of atrial fibrillation in US nursing homes: results from the National Nursing Home Survey, 1985-2004. , 2012, Journal of the American Medical Directors Association.

[27]  K. Cao,et al.  Catheter ablation of atrial fibrillation in Chinese elderly patients. , 2011, International journal of cardiology.

[28]  G. Lip,et al.  Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. , 2013, QJM : monthly journal of the Association of Physicians.

[29]  M. Franco,et al.  Impact of corticosteroids on late growth of radiofrequency lesions in infant pigs: histopathological and electroanatomical findings. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  S. Hohnloser,et al.  Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. , 1996, The American journal of cardiology.

[31]  D. Packer,et al.  Clinical Presentation, Investigation, and Management of Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation , 2005, Circulation.

[32]  Y. Sakata,et al.  Heart Failure With Preserved Ejection Fraction : What is Known and Unknown , 2009 .

[33]  D. Singer,et al.  An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.

[34]  F. Sacher,et al.  Acute Occlusion of the Left Circumflex Coronary Artery During Mitral Isthmus Linear Ablation , 2005, Journal of cardiovascular electrophysiology.

[35]  F. Morady,et al.  Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation , 2006, Circulation.

[36]  C. Antzelevitch,et al.  Antiarrhythmic Effects of Losartan and Enalapril in Canine Pulmonary Vein Sleeve Preparations , 2011, Journal of cardiovascular electrophysiology.

[37]  A. Caruso,et al.  Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide. , 1995, Archives of internal medicine.

[38]  H. Krumholz,et al.  Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. , 1993, The New England journal of medicine.

[39]  J. Dimarco.  Surgical therapy for atrial fibrillation: a first step on what may be a long road. , 1991, Journal of the American College of Cardiology.

[40]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.

[41]  B. Gersh,et al.  Epidemiology and natural history of atrial fibrillation: clinical implications. , 2001, Journal of the American College of Cardiology.

[42]  S. Mouly,et al.  Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. , 2006, Archives of internal medicine.

[43]  H. Nakagawa,et al.  Localization of Left Atrial Ganglionated Plexi in Patients with Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.

[44]  H. Halperin,et al.  Integrated Electroanatomic Mapping With Three-Dimensional Computed Tomographic Images for Real-Time Guided Ablations , 2006, Circulation.

[45]  F. Sacher,et al.  Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study , 2008, Circulation.

[46]  P. Vardas,et al.  Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study , 2000, Heart.

[47]  S. W. Halpern,et al.  Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size. , 1980, British heart journal.

[48]  I. Brill.  Auricular fibrillation with congestive failure and no other evidence of organic heart disease , 1937 .

[49]  G. Moe,et al.  On the multiple wavelet hypothesis o f atrial fibrillation. , 1962 .

[50]  Helmut Baumgartner,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[51]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[52]  M. Rich,et al.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.

[53]  Jagmeet P. Singh,et al.  Atrioventricular Nodal Ablation in Atrial Fibrillation: A Meta-Analysis and Systematic Review , 2012, Circulation. Arrhythmia and electrophysiology.

[54]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[55]  P. Vernant,et al.  [Familial auricular fibrillation]. , 1976, La Nouvelle presse medicale.

[56]  M. Turakhia,et al.  Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. , 2010, American heart journal.

[57]  Mitsuru Yamamoto,et al.  Pacing-Induced Spontaneous Activity in Myocardial Sleeves of Pulmonary Veins After Treatment With Ryanodine , 2003, Circulation.

[58]  T. Sundt,et al.  Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success? , 2007, The Annals of thoracic surgery.

[59]  Ralph Lazzara,et al.  Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[60]  M R Franz,et al.  Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. , 2000, Circulation.

[61]  A. McLellan,et al.  The Role of Adenosine Following Pulmonary Vein Isolation in Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Systematic Review , 2013, Journal of cardiovascular electrophysiology.

[62]  M. Mack,et al.  Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the "Dallas" lesion set. , 2009, Heart rhythm.

[63]  K. Bailey,et al.  A Population Study of the Natural History of Wolff‐Parkinson‐White Syndrome in Olmsted Count, Minnesota, 1953‐1989 , 1993, Circulation.

[64]  B. Gersh,et al.  Catheter Ablation for Atrial Fibrillation in Patients With Obesity , 2008, Circulation.

[65]  B. Psaty,et al.  Racial Differences in the Incidence of and Risk Factors for Atrial Fibrillation in Older Adults: The Cardiovascular Health Study , 2013, Journal of the American Geriatrics Society.

[66]  E. Kaluski,et al.  Clonidine for Patients with Rapid Atrial Fibrillation , 1992, Annals of Internal Medicine.

[67]  M. Chung,et al.  Cardioversion Guided by Transesophageal Echocardiography: The ACUTE Pilot Study: A Randomized, Controlled Trial , 1997, Annals of Internal Medicine.

[68]  A. Wear.  CIRCULATION , 1964, The Lancet.

[69]  Rita Barallon,et al.  A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. , 2013, The New England journal of medicine.

[70]  D. Hu,et al.  An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China , 2008, Journal of epidemiology.

[71]  Andreas Metzner,et al.  Unexpected High Incidence of Esophageal Injury Following Pulmonary Vein Isolation Using Robotic Navigation , 2010, Journal of cardiovascular electrophysiology.

[72]  J. Andrade,et al.  Cryoballoon Ablation for Atrial Fibrillation , 2012, Indian pacing and electrophysiology journal.

[73]  P. Macfarlane,et al.  Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke: A Randomized, Controlled Trial , 2013, Stroke.

[74]  W. Bean.  An Account of the Foxglove and Some of Its Medical Uses: Practical Remarks on Dropsy and Other Diseases. , 1963 .

[75]  N. Cook,et al.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. , 2010, European heart journal.

[76]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[77]  K. P. Link,et al.  STUDIES ON THE HEMORRHAGIC SWEET CLOVER DISEASE IV. THE ISOLATION AND CRYSTALLIZATION OF THE HEMORRHAGIC AGENT , 1941 .

[78]  S. Willems,et al.  Reduced Fluoroscopy During Atrial Fibrillation Ablation: Benefits of Robotic Guided Navigation , 2010, Journal of cardiovascular electrophysiology.

[79]  T. Etgen,et al.  Insertable Cardiac Event Recorder in Detection of Atrial Fibrillation After Cryptogenic Stroke: An Audit Report , 2013, Stroke.

[80]  H. Sievert,et al.  Percutaneous closure of the left atrial appendage. , 2003, Journal of interventional cardiology.

[81]  Haran Burri,et al.  Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[82]  J. Cummings,et al.  Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias , 1964, Circulation.

[83]  Yang,et al.  Modulation of vagal activity to atria electrical remodeling resulted from rapid atrial pacing , 2008 .

[84]  J. Madden.  Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. , 1949, Journal of the American Medical Association.

[85]  E. Boersma,et al.  Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients , 2012, European heart journal.

[86]  M. Allessie,et al.  Electrical, contractile and structural remodeling during atrial fibrillation. , 2002, Cardiovascular research.

[87]  P. Vardas,et al.  Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[88]  H. Collard,et al.  A practical guide for clinicians who treat patients with amiodarone: 2007. , 2007, Heart rhythm.

[89]  H. Calkins,et al.  Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. , 2011, Journal of the American College of Cardiology.

[90]  P. Lambiase,et al.  Constrictive pericarditis after catheter ablation for atrial fibrillation. , 2008, Circulation.

[91]  J. Mackenzie.  THE INTERPRETATION OF THE PULSATIONS IN THE JUGULAR VEINS , 1907 .

[92]  S. Bagshaw,et al.  Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. , 2006, The Annals of thoracic surgery.

[93]  H W Allen,et al.  Auricular Fibrillation. , 1913, California state journal of medicine.

[94]  N. Voorhies.  Digitalis therapy. , 1947, The Bulletin of the Tulane Medical Faculty.

[95]  R. Erbel,et al.  Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. , 2006, European heart journal.

[96]  M. Brignole,et al.  Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. , 2011, European heart journal.

[97]  D. Reda,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[98]  David Keane,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[99]  A. Hedman,et al.  Predicting the risk of atrial fibrillation after coronary artery bypass surgery , 2003, Scandinavian cardiovascular journal : SCJ.

[100]  Hsuan-Ming Tsao,et al.  Role of high dominant frequency sites in nonparoxysmal atrial fibrillation patients: insights from high-density frequency and fractionation mapping. , 2010, Heart rhythm.

[101]  L. Tavazzi,et al.  Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial. , 2009, European heart journal.

[102]  S. Jensen,et al.  Entrapment of circular mapping catheter in the mitral valve. , 2007, Heart rhythm.

[103]  J. Mounsey,et al.  Antiarrhythmic drug therapy of atrial fibrillation. , 2004, Cardiology clinics.

[104]  M. Ozdemir,et al.  Dabigatran Versus Warfarin in Atrial Fibrillation , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[105]  K. Aonuma,et al.  Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. , 2010, Journal of the American College of Cardiology.

[106]  W. Manning,et al.  Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. , 1998, Journal of the American College of Cardiology.

[107]  Sabine Ernst,et al.  Complete Isolation of Left Atrium Surrounding the Pulmonary Veins: New Insights From the Double-Lasso Technique in Paroxysmal Atrial Fibrillation , 2004, Circulation.

[108]  Felix Yang,et al.  Quinidine revisited. , 2009, The American journal of medicine.

[109]  J. Soler‐Soler,et al.  Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. , 1996, Journal of the American College of Cardiology.

[110]  K. Nademanee,et al.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.

[111]  L. Lipsitz,et al.  Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. , 1985, The Quarterly journal of medicine.

[112]  W. Rheinboldt,et al.  A COMPUTER MODEL OF ATRIAL FIBRILLATION. , 1964, American heart journal.

[113]  R. Lazzara,et al.  Spontaneous Pulmonary Vein Firing in Man: Relationship to Tachycardia‐Pause Early Afterdepolarizations and Triggered Arrhythmia in Canine Pulmonary Veins In Vitro , 2007, Journal of cardiovascular electrophysiology.

[114]  Ki H. Chon,et al.  Automatic Selection of the Threshold Value $r$ for Approximate Entropy , 2008, IEEE Transactions on Biomedical Engineering.

[115]  S. Lansman,et al.  Oral d,lsotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study☆ , 1999 .

[116]  Frank Bogun,et al.  A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. , 2009, Journal of the American College of Cardiology.

[117]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[118]  Elad Anter,et al.  Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic , 2009, Circulation.

[119]  U Ravens,et al.  L-Type Ca 2 Current Downregulation in Chronic Human Atrial Fibrillation Is Associated With Increased Activity of Protein Phosphatases , 2004 .

[120]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[121]  H. Nathan,et al.  The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. , 1966, Circulation.

[122]  S. Yusuf,et al.  Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion , 2010, Circulation.

[123]  F. Morady,et al.  Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. , 1982, JAMA.

[124]  Mark A. Wood,et al.  Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation , 1996 .

[125]  Andrea Natale,et al.  New Technologies in Atrial Fibrillation Ablation , 2009, Circulation.

[126]  W. Shen,et al.  Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials. , 2007, Heart rhythm.

[127]  J Clémenty,et al.  Radiofrequency Catheter Ablation in Unusual Mechanisms of Atrial Fibrillation: , 1994, Journal of cardiovascular electrophysiology.

[128]  G. Breithardt,et al.  Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF)-Trial Running title: Goette et al.; The ANTIPAF Trial , 2010 .

[129]  C. Sticherling,et al.  Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns. , 2010, Heart rhythm.

[130]  P B Corr,et al.  The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. , 1991, The Journal of thoracic and cardiovascular surgery.

[131]  Michel Haïssaguerre,et al.  Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation , 2002, Circulation.

[132]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 2001, Chest.

[133]  J McMichael.  History of atrial fibrillation 1628-1819 Harvey - de Senac - Laënnec. , 1982, British heart journal.

[134]  Timothy Watson,et al.  Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[135]  Otto Kamp,et al.  Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[136]  K. Cao,et al.  A Morphological Study of the Left Atrial Appendage in Chinese Patients with Atrial Fibrillation , 2012, The Journal of international medical research.

[137]  OmerBerenfeld,et al.  Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans , 2005 .

[138]  D. Packer,et al.  Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Diastolic Dysfunction: A Comparison to Systolic Dysfunction and Normal Ventricular Function , 2011, Circulation. Arrhythmia and electrophysiology.

[139]  K. Kuck,et al.  Feasibility of Circumferential Pulmonary Vein Isolation Using a Novel Endoscopic Ablation System , 2010, Circulation. Arrhythmia and electrophysiology.

[140]  J. Cox,et al.  Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. , 1999, The Journal of thoracic and cardiovascular surgery.

[141]  Xingquan Zhao,et al.  One‐year Clinical Prediction in Chinese Ischemic Stroke Patients Using the CHADS2 and CHA2DS2‐VASc Scores: The China National Stroke Registry , 2012, CNS neuroscience & therapeutics.

[142]  D. Packer,et al.  Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence , 2010, Journal of cardiovascular electrophysiology.

[143]  Charles Antzelevitch,et al.  Reinduction of Atrial Fibrillation Immediately After Termination of the Arrhythmia Is Mediated by Late Phase 3 Early Afterdepolarization–Induced Triggered Activity , 2003, Circulation.

[144]  André C. Linnenbank,et al.  Thoracoscopic Video-Assisted Pulmonary Vein Antrum Isolation, Ganglionated Plexus Ablation, and Periprocedural Confirmation of Ablation Lesions: First Results of a Hybrid Surgical-Electrophysiological Approach for Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[145]  E. Heist,et al.  Rate Control in Atrial Fibrillation: Targets, Methods, Resynchronization Considerations , 2011, Circulation.

[146]  J. Ector,et al.  Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[147]  M. J. Goldman.  The management of chronic atrial fibrillation: Indications for and method of conversion to sinus rhythm , 1960 .

[148]  Saibal Kar,et al.  Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.

[149]  J. McMurray,et al.  Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[150]  F. Marchlinski,et al.  Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. , 2004, Journal of the American College of Cardiology.

[151]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[152]  Larisa H. Cavallari,et al.  Pharmacogenetics and Cardiovascular Disease—Implications for Personalized Medicine , 2013, Pharmacological Reviews.

[153]  Th. W. Engelman.  Ueber den Einfluss der Systole auf die motorische Leitung in der Herzkammer, mit Bemerkungen zur Theorie allorhythmischer Herzstörungen , 1896, Archiv für die gesamte Physiologie des Menschen und der Tiere.

[154]  Douglas L Packer,et al.  Mechanisms of Phrenic Nerve Injury During Radiofrequency Ablation at the Pulmonary Vein Orifice , 2005, Journal of cardiovascular electrophysiology.

[155]  T. Arentz,et al.  Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[156]  D SCHERF,et al.  Studies on Auricular Tachycardia Caused by Aconitine Administration , 1947, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[157]  S. Ernst,et al.  Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins: Lessons From Double Lasso Technique , 2005, Circulation.

[158]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[159]  R. Califf,et al.  A pharmacogenetic versus a clinical algorithm for warfarin dosing. , 2013, The New England journal of medicine.

[160]  E. Kholmovski,et al.  Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. , 2010, Heart rhythm.

[161]  J. Kautzner,et al.  Associations between cardiac fibrosis and permanent atrial fibrillation in advanced heart failure. , 2013, Physiological research.

[162]  Temporary Atrial Epicardial Pacing as Prophylaxis Against Atrial Fibrillation after Heart Surgery: , 2003, Journal of cardiovascular electrophysiology.

[163]  J. Healey,et al.  Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin , 2009, Circulation.

[164]  A. Gillinov,et al.  Esophageal injury during radiofrequency ablation for atrial fibrillation. , 2001, The Journal of thoracic and cardiovascular surgery.

[165]  G. Kay,et al.  Atrial tachycardia initiating atrial fibrillation successfully ablated in the non-coronary cusp of the aorta , 2010, Journal of Interventional Cardiac Electrophysiology.

[166]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[167]  Thomas Wilke,et al.  Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[168]  H. Nakagawa,et al.  Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. , 2009, Heart rhythm.

[169]  Mandeep Bhargava,et al.  Experience with the Hansen Robotic System for Atrial Fibrillation Ablation—Lessons Learned and Techniques Modified: Hansen in the Real World , 2009, Journal of cardiovascular electrophysiology.

[170]  B K Khandheria,et al.  Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. , 1997, Circulation.

[171]  Liming Zhang,et al.  Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties , 2003, The Journal of physiology.

[172]  H. Alkadhi,et al.  Left atrial appendage clip occlusion: early clinical results. , 2010, The Journal of thoracic and cardiovascular surgery.

[173]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[174]  Philippe Pibarot,et al.  Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. , 2008, Journal of the American College of Cardiology.

[175]  Sir Thomas Lewis.  Auricular fibrillation; a common clinical condition. , 1909 .

[176]  L. Lickfett,et al.  Comparison of Cryoballoon and Radiofrequency Ablation of Pulmonary Veins in 40 Patients with Paroxysmal Atrial Fibrillation: A Case‐Control Study , 2009, Journal of cardiovascular electrophysiology.

[177]  H. Halperin,et al.  Technique and Results of Pulmonary Vein Angiography in Patients Undergoing Catheter Ablation of Atrial Fibrillation , 2004, Journal of cardiovascular electrophysiology.

[178]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[179]  S. Ommen,et al.  Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy , 2008, Journal of cardiovascular electrophysiology.

[180]  M. Brainin,et al.  Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation , 1998, Annals of Internal Medicine.

[181]  P. Wolf,et al.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[182]  S. Zelenkofske,et al.  Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery , 2010, BMC cardiovascular disorders.

[183]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[184]  P. Macfarlane,et al.  Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials , 2011, BMJ : British Medical Journal.

[185]  Rui-Xing Yin,et al.  Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 7 double-blind, placebo-controlled, randomized clinical trials , 2012, Trials.

[186]  O. Orning,et al.  The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. , 1969, The American journal of cardiology.

[187]  M. Gollob,et al.  Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. , 2006, Heart rhythm.

[188]  A. Capucci,et al.  Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. , 1994 .

[189]  G. Lip,et al.  Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[190]  P. Danias,et al.  Risk for Clinical Thromboembolism Associated with Conversion to Sinus Rhythm in Patients with Atrial Fibrillation Lasting Less Than 48 Hours , 1997, Annals of Internal Medicine.

[191]  H. Steilner,et al.  Captopril in congestive heart failure. , 1982, British journal of clinical pharmacology.

[192]  Panagiotis Korantzopoulos,et al.  Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.

[193]  A. Zanchetti,et al.  Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial , 2008, Journal of hypertension.

[194]  M. Mansour,et al.  Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. , 2002, Cardiovascular research.

[195]  G. W. Thomson,et al.  Quinidine as a Cause of Sudden Death , 1956, Circulation.

[196]  Elia Biganzoli,et al.  Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.

[197]  P. White,et al.  A CLINICAL REPORT ON THE USE OF QUINIDIN SULPHATE , 1923 .

[198]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[199]  A. Aggarwal.  Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.

[200]  V. Santinelli,et al.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[201]  C. Tai,et al.  Is 8-mm more effective than 4-mm tip electrode catheter for ablation of typical atrial flutter? , 1999, Circulation.

[202]  G. Naccarelli,et al.  Increasing prevalence of atrial fibrillation and flutter in the United States. , 2009, The American journal of cardiology.

[203]  D. Packer,et al.  Left Atrial Appendage Obliteration in Atrial Fibrillation Thoracoscopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation , 2003 .

[204]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[205]  C. Negrão,et al.  Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation , 2006, Circulation.

[206]  Prashanthan Sanders,et al.  Technique and Results of Linear Ablation at the Mitral Isthmus , 2004, Circulation.

[207]  Otto Kamp,et al.  Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. , 2004, Journal of the American College of Cardiology.

[208]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[209]  Stanley Nattel,et al.  Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications , 2008, Circulation. Arrhythmia and electrophysiology.

[210]  C. T. Layton,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia , 1996 .

[211]  P. Schauerte,et al.  Nerve supply of the human pulmonary veins: an anatomical study. , 2009, Heart rhythm.

[212]  H. Ikram,et al.  Left atrial function after electrical conversion to sinus rhythm. , 1968, British heart journal.

[213]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[214]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[215]  J. Auer,et al.  A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. , 2004, American heart journal.

[216]  Rimm,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[217]  W. C. Sheldon,et al.  Direct myocardial revascularization with saphenous vein autograft. Clinical experience in 100 cases. , 1969, Diseases of the chest.

[218]  P. O’Neill,et al.  Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. , 1990, American heart journal.

[219]  Nassir Marrouche,et al.  Atrial Fibrosis Quantified Using Late Gadolinium Enhancement MRI is Associated With Sinus Node Dysfunction Requiring Pacemaker Implant , 2012, Journal of cardiovascular electrophysiology.

[220]  A. Cushny,et al.  IRREGULARITY OF THE HEART AND AURICULAR FIBRILLATION , 1911 .

[221]  Simon Stewart,et al.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. , 2013, International journal of cardiology.

[222]  Raymond C S Seet,et al.  Prolonged Rhythm Monitoring for the Detection of Occult Paroxysmal Atrial Fibrillation in Ischemic Stroke of Unknown Cause , 2011, Circulation.

[223]  Samuel Wann,et al.  [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.

[224]  M. Zubaid,et al.  Stroke prevention in atrial fibrillation--an Asian stroke perspective. , 2013, Heart rhythm.

[225]  B. Belhassen.  Is quinidine the ideal drug for brugada syndrome? , 2012, Heart rhythm.

[226]  Affirm Investigators.  Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. , 2003, Journal of the American College of Cardiology.

[227]  M. Trivi,et al.  Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation. , 2013, International journal of cardiology.

[228]  L. E. Peterson,et al.  Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. , 1988, European heart journal.

[229]  Shuyan Li,et al.  Low-Level Vagosympathetic Stimulation: A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation , 2009, Circulation. Arrhythmia and electrophysiology.

[230]  F. Fernández‐Avilés,et al.  Mechanisms by Which Adenosine Restores Conduction in Dormant Canine Pulmonary Veins , 2010, Circulation.

[231]  P B Corr,et al.  The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.

[232]  R. Vest.  Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation , 2010 .

[233]  C. Armon.  Amiodarone for atrial fibrillation. , 2007, The New England journal of medicine.

[234]  T. Bunch,et al.  Outcomes After Cardiac Perforation During Radiofrequency Ablation of the Atrium , 2005, Journal of cardiovascular electrophysiology.

[235]  Sanjiv M Narayan,et al.  Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). , 2013, Journal of the American College of Cardiology.

[236]  S Chierchia,et al.  Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia: A New Anatomic Approach for Curing Atrial Fibrillation , 2000, Circulation.

[237]  J. Ruskin,et al.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. , 2013, Journal of the American College of Cardiology.

[238]  R. Lazzara,et al.  Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. , 2005, Heart rhythm.

[239]  W. Holland,et al.  Production of Fibrillation in Isolated Atria of Rabbit Heart , 1957, British medical journal.

[240]  Burr Hall,et al.  Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation , 2003, Circulation.

[241]  Wei-Shiang Lin,et al.  Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy , 2003, Circulation.

[242]  John Camm,et al.  Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[243]  J. Gallagher,et al.  Catheter technique for closed-chest ablation of the atrioventricular conduction system. , 1982 .

[244]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[245]  X. Freixa,et al.  The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[246]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[247]  J. You,et al.  Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? , 2005, British journal of clinical pharmacology.

[248]  E. Kholmovski,et al.  Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[249]  James B Seward,et al.  Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.

[250]  M. Wijffels,et al.  Arrhythmia Detection after Atrial Fibrillation Ablation: Value of Incremental Monitoring Time , 2012, Pacing and clinical electrophysiology : PACE.

[251]  W. W. Brabham.  Valsartan for Prevention of Recurrent Atrial Fibrillation , 2010 .

[252]  S. Kaul,et al.  Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials , 2011, Heart.